Litigation Details for ACTELION PHARMACEUTICALS LTD v. LAURUS LABS LIMITED (D.N.J. 2020)
✉ Email this page to a colleague
ACTELION PHARMACEUTICALS LTD v. LAURUS LABS LIMITED (D.N.J. 2020)
| Docket | ⤷ Sign Up | Date Filed | 2020-10-05 |
| Court | District Court, D. New Jersey | Date Terminated | 2021-01-21 |
| Cause | 35:271 Patent Infringement | Assigned To | Freda L. Wolfson |
| Jury Demand | None | Referred To | Lois H. Goodman |
| Patents | 7,094,781 | ||
| Link to Docket | External link to docket | ||
Details for ACTELION PHARMACEUTICALS LTD v. LAURUS LABS LIMITED (D.N.J. 2020)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2020-10-05 | 1 | Complaint | infringement of United States Patent No. 7,094,781 (“the ’781 patent” or “the patent-in-suit”). This action … the same plaintiff and same patent (United States Patent No. 7,094,781) that were at issue in the matters…781 patent, titled “Sulfamides and Their Use as Endothelin Receptor Antagonists.” The ’781 patent duly…of the ’781 patent, Laurus and PharmaQ have infringed one or more claims of the ’781 patent under 35 U.S.C…expiration date of the ’781 patent, or any later expiration of any patent term extension or exclusivity | External link to document |
| 2021-01-20 | 14 | Letter | ii) the term “Licensed Patent” shall mean United States Patent Number 7,094,781; and (iii) the term “Affiliate…the Licensed Patent are valid and enforceable, and that the claims of the Licensed Patent would be infringed…Laurus Product prior to expiration of the Licensed Patent. 4. Unless otherwise specifically…assigns, is enjoined from infringing the Licensed Patent, on …2020 22 January 2021 3:20-cv-13967 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| 2021-01-21 | 15 | Judgment - Consent | ii) the term “Licensed Patent” shall mean United States Patent Number 7,094,781; and (iii) the term “Affiliate…the Licensed Patent are valid and enforceable, and that the claims of the Licensed Patent would be infringed…Laurus Product prior to expiration of the Licensed Patent. 4. Unless otherwise specifically…assigns, is enjoined from infringing the Licensed Patent, on …2020 22 January 2021 3:20-cv-13967 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
